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van Leeuwen's Response
In our paper, "Toxic Equivalency Factors
(TEFs) for PCBs, PCDDs, PCDFs for
Humans and Wildlife" (1), we described the
results of a World Health Organization
(WHO) working group that evaluated the
existing TEFs for human risk assessment and
derived consensus TEFs for fish and birds.
Starr et al. comment on the approach
taken for the derivation of TEFs as
described in our paper (1) and criticize the
inadequate characterization of the uncer-
tainty ofthe TEFs. They state that the fol-
lowing sentence is the only uncertainty
characterization:
... it is unlikely for the use ofthis additive model
to result in a great deal oferror in predicting the
concentrations of TCDD TEQs or responses at
environmentally relevant levels due to nonaddi-
tive interactions.
In addition, they request explicit quantita-
tive estimates on the uncertainty in each
REP value, each TEF, and on the deviation
from parallelism for the different end points.
Their first statement is incorrect. In the
paper we clearly stated that the TEFs that
were derived are "an order of magnitude
estimate." This is a clear illustration of the
overall uncertainty in TEF values based on
the differences in outcomes ofthe different
end points and the variation in available
data for the different congeners. In addi-
tion, Starr et al. misinterpreted the sentence
quoted above. This sentence is based on the
opinion ofVan den Berg et al. (1) that the
use of an additive model in the TEF
approach, in contrast to including nonad-
ditive (synergistic or antagonistic) effects,
does not result "in a great deal oferror."
Providing a quantitative estimate of the
uncertainty of the individual REPs, as
requested by Starr et al., is often not possible.
Uncertainty in no-observed-(adverse)-effect
levels [or lowest-observed-(adverse)-effect lev-
els] or EC50 is usually not given in the stud-
ies used by the WHO working group.
Therefore, a more qualitative, tiered
approach was chosen to select the REPvalues
in which we had greatest confidence, and not
because we believe they are "without error."
This weighted procedure is clearly outlined
in the original paper. For those scientists who
want to address the variation in REP values
in more detail, the database containing all the
information that was used in the derivation
ofTEFs is available on request. In their com-
ments, Starr et al. suggestively stated that
"the database is said to be available." The
database was available directly after the
WHO TEF meeting that was held in June
1997. Requests were received from several
people, and all ofthem received the data.
Regarding their comment on the
requirement of "parallelism of dose-
response curves across end points" Starr et
al. apparently failed to understand that the
cascade of events following binding to the
Ah receptor is different for each end point,
which might thus result in different
dose-response curves. Basic pharmacology
and endocrinology have shown that multi-
ple responses mediated by the same recep-
tor mechanism do not have to have parallel
dose-response curves because binding to a
receptor is but the first step in the cascade
of responses. Thus, per definition, the
dose-response curves for different health
end points cannot be expected to be paral-
lel. This is one of the inherent uncertain-
ties in the derivation of TEFs, but this is
well recognized and covered adequately by
Van den Berg et al. (1). Parallel
dose-response curves are required for dif-
ferent congeners examining the same
response, but this has been amply demon-
strated in the literature for various dioxins,
furans, and PCBs for various responses,
and it was adequately covered by Van den
Berg et al.
Where Starr et al. criticize the current
approach and advocate the derivation of
"species-, end point-, and dose-specific
TEFs," it should be mentioned that the
lack of information on dose-response rela-
tionships for all congeners, all end points/
responses, and all species was just one of
the reasons to develop the TEF methodolo-
gy. It is highly unlikely that we could test
all the congeners for all relevant end points
and all species, including humans.
Finally, the TEF approach is a risk
assessment tool; it was not developed to
produce precise estimates of risk, but to
approximate the toxic potency ofexposure
to a mixture ofdioxin-like compounds. As
such, it appears to work remarkably well. A
large number ofstudies published in peer-
reviewed literature have demonstrated a
statistically highly significant correlation
between TEQ levels in complex mixtures,
derived by making use of TEFs, and pre-
dicted health outcomes in different animal
species. An overview of this can be found
in a series of articles in Human and
Ecological Risk Assessment, Volume 5
(1999), in which several of these studies
have been cited. Thus, we conclude that
although the TEF approach might not be
perfect because of its inherent uncertain-
ties, no valid alternative for risk assessment
purposes currently exists.
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Safe Food: Should We Be
Afraid?
I would like to comment on the article
"Safe Food: An All-consuming Issue" (1). I
consider this article to be scaremongering.
Scaremongering, a very real and increasingly
dangerous problem, often with total disre-
gard to the truth, has become a major, and
obviously profitable, growth industry
wherein "nonprofit" organizations and vari-
ous individuals prosper at the expense ofthe
credulous public. Just how credulous can
the public be? This week I had a vivid
example when my wife of 55 years, on the
basis of a recent article, told me she would
no longer serve me meat products such as
salami and summer sausage, which I have
been happily consuming for most ofmy life!
True, meat contamination by such
organisms as Salmonella and new virulent
mutant strains of Escherichia coli kills many
people every year, usually in fresh ground
meat. These deaths are totally avoidable by
the appropriate use of irradiation. I have
worked with or studied food irradiation since
1950 and know that, worldwide, hundreds
ofinvestigations have shown food irradiation
to be totallyeffective andcompletelysafe.
Yet Schmidt cites Food and Water mere-
ly as a "nonprofit advocacy organization."
How could he! This is the organization that
spends quite extraordinary amounts of
money proclaiming that anyone who eats
irradiated foods is likely to have severely
deformed children (among other horrors).
I could fill many pages with accounts of
encounters with some these dangerous
frauds, and over the years I have written
several articles on the topic ofscaremonger-
ing in the food industry (2-4).
I am old (81) and long retired (since
1982), and I profoundly hope that some-
time soon a publication such as EHP will
give the same concern to this scandal as you
would to any other virulent epidemic.
Thank you for this chance to blow off
some steam.
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